Flux through metabolic pathways is inherently sensitive to the levels of specific substrates and products, but cellular metabolism is also managed by integrated control mechanisms that sense the nutrient and energy status of a cell or organism. The mechanistic target of rapamycin complex 1 (mTORC1), a protein kinase complex ubiquitous to eukaryotic cells, has emerged as a critical signalling node that links nutrient sensing to the coordinated regulation of cellular metabolism. Here, we discuss the role of mTORC1 as a conduit between cellular growth conditions and the anabolic processes that promote cell growth. The emerging network of signalling pathways through which mTORC1 integrates systemic signals (secreted growth factors) with local signals (cellular nutrients -amino acids, glucose and oxygen -and energy, ATP) is detailed. Our expanding understanding of the regulatory network upstream of mTORC1 provides molecular insights into the integrated sensing mechanisms by which diverse cellular signals converge to control cell physiology.
All cells and organisms must coordinate their metabolic activity with changes in their nutrient environment. This is achieved through signalling networks that integrate the sensing of local and systemic nutrient and energy sources, and relay this information to metabolic regulators and enzymes to control cellular anabolic and catabolic processes. One of the master regulators of metabolism and growth is the serine/threonine protein kinase mechanistic target of rapamycin (mTOR; formerly known as mammalian TOR). As part of mTOR complex 1 (mTORC1), it functions at the convergence point of a vast signalling network that senses fluctuations in extracellular and intracellular nutrients. The critical importance of intimately linking nutrient signals to metabolic control in human health is highlighted by the fact that aberrant regulation of mTORC1 signalling has been implicated in the pathophysiology of a diverse set of common human diseases, including cancer, metabolic diseases, neurological disorders, and inflammatory and autoimmune diseases [1] [2] [3] [4] . mTORC1, comprised of three essential and evolutionarily conserved core subunits (mTOR, Raptor and mLST8) 3, 5 , is responsive to both organismal and cellular nutritional status, and controls downstream metabolic processes accordingly. Systemic changes in the metabolism of the organism are sensed by mTORC1 through pathways activated by secreted growth factors, cytokines and hormones. Activation of mTORC1 is also dependent on sufficient levels of essential intracellular nutrients, including amino acids, glucose and oxygen. Nutrients seem to be the more ancient input for mTORC1, as its activation in yeast depends strictly on nutrient availability 5 . In higher eukaryotes, cell culture experiments suggest that intracellular nutrients only basally activate mTORC1 but are essential for its robust stimulation by extracellular growth factors 6, 7 .
Here, we focus on mTORC1 as a key link between nutritional status and metabolic control, with an emphasis on recent advances in understanding the mechanisms of nutrient sensing and signal integration by this protein kinase complex.
Promotion of anabolic metabolism downstream of mTORC1
To understand the physiological importance of the network of signalling inputs upstream of mTORC1, we must first consider the downstream processes regulated by mTORC1. Under nutrient and energy-replete conditions, mTORC1 is activated to stimulate anabolic processes that convert nutrients and energy into macromolecules, including protein, lipid and nucleic acids. The control of cellular and systemic metabolism by mTORC1 signalling has been the subject of several recent review articles 2, 3, [8] [9] [10] , and we briefly summarize some of the major mechanisms of metabolic regulation here (Fig. 1) .
Best known for its role in promoting protein synthesis, mTORC1 activation leads to both an acute increase in the translation of specific mRNAs and a broader increase in the protein synthetic capacity of the cell. mTORC1 regulates 5´-cap-dependent mRNA translation through two sets of direct downstream targets: the eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BP1 and 2) and the ribosomal S6 kinases (S6K1 and 2) 11 . 4E-BP appears to have the most profound effect on mRNA translation downstream of mTORC1, binding to eIF4E at the 5´-cap of mRNAs and blocking assembly of the translation initiation complex. The phosphorylation of 4E-BP1 and 2 by mTORC1 stimulates its release from eIF4E, allowing translation initiation to proceed. This mechanism is particularly important for initiating the translation of mRNAs with 5´-terminal oligopyrimidine (5´-TOP) or 5´-TOP-like motifs, rendering this class of mRNAs sensitive to mTORC1 activation and inhibition [12] [13] [14] . Importantly, 5´-TOP mRNAs are enriched for those encoding ribosomal proteins and translation factors. Therefore, the acute translational control over this class of mRNAs allows mTORC1 signalling to globally enhance cellular protein synthesis. Additional mTORC1-dependent mechanisms are also believed to contribute to its role in increasing ribosome biogenesis to promote protein synthesis 15 . mTORC1 signalling can also promote lipid and nucleic acid synthesis, as well as stimulate glucose uptake, glycolysis and NADPH production to support these anabolic processes. This is currently understood to occur largely through the regulation of transcription factors by mTORC1 16 , but post-translational mechanisms have also recently been uncovered 17, 18 . For example, mTORC1 signalling increases the translation of hypoxia-inducible factor 1α (HIF1α), which induces expression of glucose transporters and glycolytic enzymes and promotes a switch from mitochondrial oxidative metabolism to glycolysis [19] [20] [21] [22] [23] [24] . This switch to aerobic glycolysis, referred to as the Warburg effect in cancer cells, is observed in most proliferating cells, and is believed to promote metabolic flux from intermediates of glycolysis into biosynthetic branches 25 . The sterol regulatory element-binding proteins (SREBP1 and 2) globally induce the expression of enzymes involved in de novo fatty acid and sterol biosynthesis 26 , and mTORC1 signalling promotes lipid synthesis through the activation of these transcription factors 19, 27, 28 . mTORC1 signalling also promotes the expression of pentose phosphate pathway (PPP) genes and metabolic flux specific to the oxidative, NADPH-producing branch of the PPP (ref. 19 ). The mTORC1-induced expression of the rate-limiting enzyme in the oxidative PPP, glucose-6-phosphate dehydrogenase (G6PD), was found to be dependent on SREBP1. Given that lipid synthesis is one of the most NADPH-demanding metabolic pathways, its co-regulation with the oxidative PPP by mTORC1 and SREBP is likely to help satisfy this requirement. Of equal importance, the mTORC1-mediated control of the PPP also results in increased production of ribose required for nucleotide synthesis 19 . In parallel to this transcriptional mechanism, mTORC1 also acutely stimulates metabolic flux through de novo pyrimidine synthesis through the S6K1-mediated phosphorylation of the enzyme CAD (carbamoyl phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), thereby increasing the pool of nucleotides available for RNA and DNA synthesis 17, 18 . As well as promoting the synthesis of macromolecules, mTORC1 potently inhibits autophagy (or macroautophagy), a cellular recycling and quality control mechanism. Autophagy is a multi-stage process in which membranous structures called autophagosomes engulf cytosolic organelles and macromolecules and, through fusion with lysosomes, target their constituents for degradation into nutrient building blocks 29 .
Under nutrient-rich, growth-promoting conditions, inhibition of this catabolic process favours cell growth. It is likely that mTORC1 inhibits autophagy at multiple steps, but the most well-characterized mechanism is through the direct control of ULK1 (also known as ATG1), a protein kinase that regulates the initiation of autophagosome formation [30] [31] [32] [33] . mTORC1 also directly phosphorylates the transcription factor EB (TFEB), a master regulator of lysosomal and autophagy genes, thereby exerting an inhibitory input that is likely to attenuate autophagy 34, 35 . The major signals that stimulate the induction of autophagy include cellular nutrient and energy depletion, which lead to a decrease in mTORC1 signalling and relief of its inhibition of autophagy.
The general effect of mTORC1 activation is to promote an increase in biomass for cell growth and proliferation. However, mTORC1 signalling plays specialized roles in terminally differentiated tissues, such as promoting localized mRNA translation in neurons, which is critical for the control of synaptic plasticity 36 , and suppression of ketogenesis in the liver following feeding 37 . Regardless of the setting, nutrient sensing by mTORC1 serves as a critical decision point between anabolic and catabolic metabolism. The broad control that mTORC1 exerts over metabolism provides a rationale for why it must be particularly responsive to the local and systemic availability of metabolic raw materials.
Systemic nutrient sensing through secreted growth factors Systemic integration of signals reflecting the physiological state of the organism, including nutritional status, is critical for maintaining homeostasis. These signals are communicated between tissues and cell types through secreted ligands classified as growth factors, hormones and cytokines (collectively referred to as growth factors here). The archetypal systemic nutrient signal is insulin, which is produced by pancreatic β cells in response to increased blood glucose levels and stimulates adaptive signalling events in liver, fat and muscle. mTORC1 is activated by insulin and most other growth factors through either receptor tyrosine kinases (RTKs) or G-protein-coupled receptors (GPCRs) at the cell surface. Downstream of these receptors, two major signalling pathways are involved in mTORC1 activation: the phosphatidylinositol-3-OH kinase (PI(3)K)-Akt and Ras-Erk pathways (Fig. 2) . These pathways are differentially activated downstream of specific receptors, with the PI(3) K-Akt pathway dominating downstream of the insulin and insulin-like growth factor (IGF) receptors. Importantly, many components of these signalling pathways are oncogenes or tumour suppressors, resulting in growth-factor-independent activation of mTORC1 in up to 80% of human cancers, across nearly all lineages 1 (Fig. 2 ). Growth-factor-dependent pathways stimulate mTORC1 signalling by regulating a small G protein switch directly upstream of mTORC1. Rheb (Ras homolog enriched in brain) is a ubiquitous small GTPase of the Ras superfamily, which, in its GTP-bound form (Rheb GTP ), is a direct, potent and essential activator of mTORC1 [38] [39] [40] [41] [42] [43] [44] . The Akt and Erk protein kinases promote the accumulation of Rheb GTP by phosphorylating and inhibiting the tuberous sclerosis complex 2 (TSC2) protein, a GTPaseactivating protein (GAP) specific for Rheb. TSC2 functions in a complex (referred to here as the TSC complex) containing two other proteins, tuberous sclerosis complex (TSC1) and Tre2-Bub2-Cdc16 (TBC) 1 domain family member 7 (TBC1D7), which are required for the stability and full GAP activity of TSC2 (refs 40,45) . In the absence of growth factor signalling, the TSC complex maintains Rheb in its GDP-bound state (Rheb GDP ), thereby blocking the activation of mTORC1. Although the molecular mechanism is not well understood, phosphorylation of specific residues on TSC2 by Akt and Erk, as well as Rsk downstream of Erk (Fig. 2, inset) , in response to growth factors, inhibits the ability of the TSC complex to regulate Rheb, allowing Rheb GTP to accumulate and activate mTORC1 (refs 46-51) . Other parallel mechanisms can also contribute to mTORC1 regulation by growth factors, including the Akt-mediated phosphorylation of PRAS40, a non-essential component of mTORC1 (refs 44,52) , and the Erk and Rsk-dependent phosphorylation of Raptor (Fig. 2) 53-55 . However, the TSC complex is absolutely essential for inhibition of mTORC1 signalling in the absence of growth factors. It is now recognized that many, but not all, upstream inputs into mTORC1 signalling impinge on control of the TSC complex and Rheb 56 . Thus, growth factor signalling pathways stimulate an acute and robust increase in mTORC1 activity. However, they can also contribute to mTORC1 activation more indirectly through the stimulated uptake of nutrients, which are essential for the basal activation of mTORC1, as discussed below.
Amino acid sensing through the Rag GTPases Amino acids are essential for mTORC1 activation 7 . Cell culture experiments suggest that mTORC1 is particularly sensitive to decreases in leucine, arginine or glutamine 7, 57, 58 . However, it is unclear whether mTORC1 truly senses individual amino acids or the total intracellular pool of amino acids, which can be differentially affected by removal of specific amino acids. It is believed that an intracellular sensor exists that probably interacts directly with amino acids, or their derivatives, and initiates a signalling mechanism to basally activate mTORC1 and allow its further stimulation by growth factors. Whereas the molecular nature of the upstream amino acid sensor is currently unknown, progress has been made on the mTORC1 proximal signalling mechanism by which the amino acid sensor ultimately communicates to mTORC1.
Rheb is essential for amino acids to activate mTORC1, but the primary amino acid sensing pathway appears to function in parallel to Rheb 59, 60 and involves a second class of small G proteins, the Rag GTPases [61] [62] [63] . The Rag proteins belong to a highly conserved family of GTPases that consist of two subtypes, which associate to form heterodimers essential for their stability and function. In mammals, RagA or RagB (orthologues of the budding yeast protein Gtr1) form a heterodimer with RagC or RagD (orthologues of yeast Gtr2) 64 . . In both mammalian and Drosophila melanogaster cells, expression of constitutively GTP-bound mutants of RagA or RagB renders mTORC1 signalling resistant to amino acid starvation, but not to growth factor withdrawal 62, 63 . The critical nature of the nucleotide-loading state of the RagA/B subunit in amino acid sensing by mTORC1 was further confirmed with a mouse knock-in allele of RagA that is constitutively bound to GTP, which in the homozygous state renders mTORC1 signalling in cells and tissues resistant to nutrient withdrawal 65 . However, unlike Rheb GTP , the RagA/B GTP -RagC/D GDP heterodimer does not seem to directly activate mTORC1, but rather spatially regulates mTORC1 in a manner that permits its ultimate activation by Rheb (Fig. 3) .
A major breakthrough in understanding the spatial regulation of mTORC1 came with the discovery of a protein complex dubbed the Ragulator, which is responsible for both the subcellular localization of the Rags and regulation of their nucleotide-binding state 66, 67 . In yeast, Gtr1-Gtr2 heterodimers interact with Ego1 and Ego3 to form the EGO complex, which associates with the outer surface of the vacuole, the yeast equivalent of the lysosome 5, 61 . In mammalian cells, RagA/B-RagC/D heterodimers localize to the lysosome through an interaction with the Ragulator, which is similar in architecture to the EGO complex but whose components are not orthologues of the Ego proteins 66 . Among the five Ragulator subunits (LAMTOR1-5), LAMTOR1 (also known as p18) anchors the pentameric complex, and hence the Rag heterodimers, to the lysosomal surface via dual N-terminal lipid modifications (myristoyl and palmitoyl moieties). LAMTOR2 (also known as p14), LAMTOR3 (also known as MP1), LAMTOR4 (also known as C7orf59), and LAMTOR5 (also known as HBXIP) share common structural elements called Roadblock domains, which are also present in the Rag proteins but serve an unknown molecular function 67, 68 . Like the Rag proteins, all components of the Ragulator are required for amino acid sensing to mTORC1 (refs 66,67) . mTORC1 acutely translocates to the Rag-Ragulator complex at the lysosome in response to amino acid re-feeding, and this requires a switch to the activated RagA/B GTP -RagC/D GDP state 66, 67 . This translocation to the lysosome is both necessary and sufficient for amino acid sensing by mTORC1. Importantly, the Ragulator not only serves as a lysosomal scaffold, but also stimulates the nucleotide switch in the Rag proteins in response to amino acids by acting as a guanine nucleotide exchange factor (GEF) towards RagA and RagB (ref. 67 ). The molecular origin of this activity within the pentameric complex is unknown, but it induces the RagA/B subunit within Rag heterodimers to release GDP, allowing subsequent loading with GTP. Through an unknown mechanism, this change coincides with a switch of the RagC/D subunit from a GTP-to GDP-bound form. Therefore, by promoting the RagA/B GTP -RagC/D GDP state, the Ragulator GEF activity stimulates the recruitment of mTORC1 to the lysosome in response to amino acids. heterodimers that accumulate are unable to recruit mTORC1 to the lysosome. In the presence of amino acids, which enter the lysosome, an unknown signal or sensor within the lysosomal lumen triggers a conformational change within the v-ATPase that, through direct interactions, promotes Ragulator GEF activity. In this manner, amino acids stimulate the formation of RagA/B GTP -RagC/D GDP heterodimers, which bind directly to mTORC1 and recruit the inactive kinase complex to the lysosomal surface. (b) The amino acid signal allows mTORC1 to come in contact with its essential upstream activator Rheb. In the absence of growth factors, Rheb is maintained in its GDP-bound state through the GAP activity of the TSC complex, and mTORC1 remains inactive. Growth factor signalling inhibits the TSC complex, allowing formation of Rheb GTP , which binds to and activates mTORC1.
How amino acids are sensed by the Ragulator at the lysosome is unknown, but seems to involve intra-lysosomal amino acids and v-ATPase, a large protein complex spanning the lysosomal membrane that acts as proton pump to acidify the lysosome 69 . The v-ATPase complex was found to be essential for amino acid sensing by mTORC1 in both Drosophila and mammalian cells. Ragulator subunits co-purify with those of v-ATPase, and the two complexes make multiple contacts that vary in the presence or absence of amino acids. Importantly, v-ATPase catalytic activity is required for an amino-acid-induced conformational shift between the two complexes and the stimulation of the switch to the RagA/B GTP -RagC/D GDP state that recruits mTORC1 to the lysosome. However, this mechanism does not seem to involve the lysosomal proton gradient. Therefore, it seems that v-ATPase stimulates the GEF activity of the Ragulator in response to amino acids 67 . Somewhat unexpectedly, it was found that that signals affecting the v-ATPase-Ragulator interactions and mTORC1 activation originate from intralysosomal, rather than cytosolic, amino acids 69 . These data provide compelling evidence that the unknown amino acid sensor lies at, and probably within, the lysosome.
Here, we briefly discuss a few of the many other factors that have been found to influence amino acid sensing by mTORC1. For any putative amino-acid-sensing pathway upstream of mTORC1, it will be critical to determine how it interfaces with the Rag proteins, as their regulation seems to represent the most proximal event to mTORC1 activation in response to amino acids. Leucyl-tRNA synthetase (LRS) has been proposed through independent studies in yeast 70 and mammalian cells 71 to function as an amino acid sensor that regulates the Rag proteins, but major mechanistic differences exist between these studies. Most notably, the yeast study suggested that LRS regulates Gtr1, the RagA/B orthologue, whereas the mammalian study suggested specific regulation of RagD, a Gtr2 orthologue. Another study has indicated that p62 (also known as sequestrome 1, or SQSTM1), which targets proteins for degradation via autophagy and is itself a substrate of autophagy, is involved in amino acid sensing by mTORC1 through a direct interaction with RagC/D (ref. 72). However, unlike components of the RagRagulator circuit, p62 is dispensable for insulin to stimulate mTORC1. MAP4K3 (mitogen-activated protein kinase kinase kinase kinase 3) is activated in response to amino acids and functions upstream of the Rag GTPases to promote mTORC1 signalling in both Drosophila and mammalian systems [73] [74] [75] . Understanding the nature of the molecular connection of MAP4K3 to both amino acids upstream and the Rags downstream requires further study. Interestingly, the two deamination steps of glutaminolysis, which convert glutamine to α-ketoglutarate, have been shown to influence the ability of leucine and glutamine to stimulate mTORC1 signalling 76 . Although the molecular basis of this link is unknown, it seems that glutaminolysis promotes GTP-loading of RagB, and the product α-ketoglutarate can stimulate mTORC1 translocation to the lysosome even in the absence of amino acids. The vertebrate-specific protein SH3BP4 has been found to directly bind to the Rags and attenuate the stimulation of mTORC1 signalling by amino acids 77 . The relationship between other emerging amino-acid-sensing pathways and the Rag GTPases is poorly understood. These include the class III PI(3)K Vps34 and phospholipase D (discussed further in Box 1), the G-protein-coupled taste receptors T1R1 and T1R3 (ref. 78) , and the inositol polyphosphate multikinase (IMPK) 79 . It is clear from these and other studies that there will be many cellular pathways and processes that impinge, either directly or indirectly, on the emerging amino-acid-sensing system at the lysosome to influence the basal state of mTORC1 activation.
Integrating nutrient sensing with growth factor signalling It has been proposed that spatial regulation of mTORC1 through the Ragulator-Rag circuit, in conjuction with its requirement for the GTP-loading of Rheb, serves as a coincidence detector or a molecular 'and gate' , allowing a hierarchy of signals to be integrated by mTORC1
Relatively little is known about how intracellular and dietary lipids influence mTORC1 signalling. Two lipid signalling molecules found on endomembranes, phosphatidylinositol-3-phosphate (PtdIns(3)P) and phosphatidic acid -and the enzymes that produce them, Vps34 and phospholipase D (PLD), respectively -have been found to promote mTORC1 signalling in some settings [127] [128] [129] . These enzymes and phospholipids have been partially localized to late endosomes and lysosomes, and their regulation of mTORC1 signalling might be tied together. The activities of Vps34 and PLD seem to be responsive to both amino acids and glucose, and their knockdown can impair acute mTORC1 activation by these nutrients [130] [131] [132] [133] [134] , although it has been pointed out that these effects can often be compensated for under steady-state conditions 128 . Through the production of PtdIns(3)P, Vps34 activity has been proposed to recruit PLD to the lysosome, where its product phosphatidic acid is believed to stimulate mTORC1 (refs 128,133) . However, genetic ablation of Vps34 in Drosophila or in specific mouse tissues has no apparent effect on mTORC1 signalling 135, 136 , and PLD-deficient flies as well as PLD1 -/-and PLD2 -/-mice are viable, suggesting a non-essential role for these enzymes in activating mTORC1 (refs 137,138) . It is worth noting that other cellular sources of these lipids do exist, but the enzymes responsible for their production have not been specifically implicated in mTOR signalling. Further studies are required to clarify how these lipid signalling pathways fit into the emerging model of spatial integration of signals by mTORC1 at the lysosome. In mammals, high-fat diets and obesity are associated with elevated mTORC1 signalling in metabolic tissues, which is believed to contribute to the development of insulin resistance under such conditions [139] [140] [141] [142] . The molecular nature of this chronic mTORC1 activation and whether there are cell-autonomous effects of dietary lipids on mTORC1 signalling are not well understood. Free fatty acids have been described in a few studies to acutely stimulate mTORC1 signalling [142] [143] [144] [145] [146] . The upstream events that mediate this effect are unknown but could depend on either energy production through the β-oxidation of fatty acids or signalling from extracellular fatty acids engaging specific GPCRs 147 . However, it is somewhat paradoxical that mTORC1 would be activated by free fatty acids, given that it can promote the de novo synthesis of fatty acids through its induction of SREBP (refs 19,27) . The relationship between lipid sensing and synthesis by mTORC1 remains an important area of investigation, as aberrant activation of mTORC1 under conditions of obesity is believed to be a molecular factor underlying many of the pathological manifestations of obesity. (refs 3,66) . Whereas growth factor signalling pathways that increase Rheb GTP levels by impinging on the TSC complex are required for maximal mTORC1 activation, they fail to activate mTORC1 in the absence of amino acids. Rheb localizes on the surface of multiple endomembrane compartments, at least in part through a C-terminal sequence that is farnesylated [80] [81] [82] , a modification required for Rheb to activate mTORC1 signaling 40, 83 . Importantly, a subpopulation of Rheb resides at the lysosome 66 . Therefore, the recruitment of mTORC1 to this compartment through the Ragulator-Rag system in response to amino acids brings mTORC1 in contact with its essential upstream activator Rheb (Fig. 3b) . This mechanism helps explain the dominance of amino acid signalling over growth factor signalling to mTORC1. Through the lysosomal shuttling of mTORC1, the amino-acid-sensing pathway facilitates the association of Rheb and mTORC1, but the ultimate activation of mTORC1 seems to be determined by the GTP/GDP-loading state of Rheb, which is controlled by the TSC complex. Interestingly, growth factor signalling pathways might also impinge on Rheb regulation directly at the lysosome, as the TSC complex also localizes to the lysosomal surface 45 . This current spatial model of signal integration is enticing, but it will be important to more completely define the molecular mechanisms and temporal nature of these and other signals influencing both the activation and inhibition of mTORC1 signalling.
BOX 1 Signals from endogenous and dietary lipids
Multiple inputs from glucose, oxygen and cellular energy levels As well as amino acids, the presence of two other essential cellular nutrients, glucose and oxygen, are sensed by mTORC1; they are also required for both its basal and growth-factor-stimulated activation. A decrease in the availability of glucose or oxygen to cells results in profound changes in cellular metabolism and can cause an acute, but often transient, drop in cellular energy levels, in the form of ATP. Cells respond to such changes by tipping the metabolic balance from anabolic processes that consume energy and carbon (for macromolecular biosynthesis) to catabolic pathways that produce energy. As a major promoter of anabolic processes, mTORC1 is a key target in this metabolic adaptation and is negatively regulated by decreases in glucose, oxygen and/ or energy levels [84] [85] [86] . This regulation is now known to occur through multiple interconnected adaptive response mechanisms lying upstream of mTORC1 (Fig. 4) . Figure 4 Transcriptional and post-translational regulation of mTORC1 by glucose, oxygen and cellular energy. Sufficient glucose and oxygen levels are required for mTORC1 activation, and many sensing mechanisms have been identified. Glucose, glutamine and oxygen are utilized for ATP production through glycolysis, the citric acid (TCA) cycle and oxidative phosphorylation (ox. phos.). Decreased availability of these nutrients can lower ATP levels, with a subsequent rise in AMP levels -conditions that stimulate the activation of AMPK. AMPK inhibits mTORC1 through activation of the TSC complex (which inhibits Rheb) and phosphorylation of Raptor within mTORC1. Glucose or oxygen deprivation, as well as other forms of energy stress, also stimulates the transcription of REDD1 through the action of either the HIF1, ATF4 or p53 transcription factors. REDD1 somehow cooperates with the TSC complex to inhibit Rheb and mTORC1. Through their sensing of AMP and oxygen, respectively, AMPK and the prolyl hydroxylase proteins (PHD) represent the only known direct sensors of cellular metabolic status within this network. As well as energy stress, glucose and oxygen can also be sensed through endoplasmic reticulum (ER) homeostasis, as they are required for proper protein glycosylation and disulfide bond formation, respectively. Disrupting these processes results in activation of PERK and inhibition of eIF2a, resulting in the selective translation of ATF4. Glucose starvation and energy stress also seem to signal to mTORC1 through the Rag GTPases, albeit through unknown mechanisms, and through a pathway involving the p38β and PRAK kinases (leading to direct phosphorylation of Rheb). Inset box: severe states of ATP depletion inhibit the ability of the TTT-RUVBL1/2 complex to promote formation of functional mTORC1 dimers. Note that mTORC1 is depicted as a single unit at the lysosome for simplicity. Compounds such as 2-deoxyglucose (2-DG), AICAR and the biguanides metformin and phenformin also have inputs into these different mechanisms of mTORC1 inhibition. Dashed lines denote unknown molecular mechanisms.
One of the first lines of defence against energy stress -defined as the depletion of cellular ATP -is acute activation of the AMP-dependent protein kinase (AMPK), which is activated by even subtle decreases in cellular ATP levels 87 . Through numerous downstream targets, AMPK initiates an adaptive program that promotes catabolic metabolism and inhibits anabolic processes. For instance, AMPK stimulates autophagy while inhibiting lipid and protein synthesis 33, [87] [88] [89] . Critical to this adaptive response is the inhibition of mTORC1 signalling, which occurs through the AMPK-mediated phosphorylation of at least two pathway components, TSC2 and Raptor. Through phosphorylation of TSC2 on Ser 1387, which acts as a priming event for subsequent phosphorylation of more sites by GSK3, AMPK promotes the inhibition of Rheb and mTORC1 by the TSC complex [90] [91] [92] . Hence, loss of any TSC complex component renders the mTORC1 pathway at least partially resistant to energy-stressinducing conditions, including glucose starvation, inhibition of glycolysis or oxidative phosphorylation, or hypoxia 45, 90, [92] [93] [94] . AMPK has also been found to have a direct inhibitory effect on mTORC1 by phosphorylating Raptor on Ser 792 (ref. 95) . The relative contributions of the AMPKmediated activation of the TSC complex, resulting in decreased levels of Rheb GTP and this more direct inhibition of mTORC1, are unknown. However, one possibility is that Raptor phosphorylation blocks basal activation of mTORC1, whereas AMPK-mediated phosphorylation of TSC2 overrides growth factor signalling through the TSC complex that would otherwise activate mTORC1. Importantly, the regulation of mTORC1 by AMPK renders mTORC1 signalling sensitive to a rapidly expanding list of chemicals, xenobiotics and natural products that activate AMPK, including commonly prescribed drugs such as metformin and aspirin 96 . Another major regulator of mTORC1 signalling that is involved in the adaptation to hypoxia, glucose starvation and perhaps other cellular stresses is the protein REDD1 (regulated in development and DNA damage responses 1; also known as DDIT4, Dig2 and RTP801). The Drosophila orthologues of REDD1 were identified in a genetic screen for regulators of cell growth, with their overexpression or loss resulting in a respective decrease or increase in cell and organ growth, similarly to that observed with TSC1 and TSC2 (ref. 97) . Importantly, hypoxia stimulates the expression of these genes and mammalian REDD1 through the stabilization and activation of HIF1 97, 98 -which, in the presence of oxygen, is degraded through the action of oxygen-dependent prolylhydroxylases and the von-Hippel Lindau (VHL) E3 ubiquitin ligase 99 . The HIF1-mediated induction of REDD1 seems to be required for the sustained inhibition of mTORC1 signalling under hypoxia 93 (that is, 1% oxygen). Genetic and cell biological evidence indicates that REDD1 inhibits mTORC1 signalling through the TSC complex, although the mode of action of REDD1 has yet to be fully elucidated 93, 97, 100, 101 . The activation of HIF1, its induction of REDD1, and the subsequent inhibition of mTORC1 signalling in response to hypoxia, seems to also require upstream input from the ATM tumour suppressor, a protein kinase best known for its role in the DNA-damage response 102 . Interestingly, REDD1 is also required for the inhibitory effects of energy stress on mTORC1 signalling, including the effects induced by glucose starvation, 2-deoxyglucose, and metformin 103, 104 . Under these and other stress conditions that inhibit mTORC1, it is likely that REDD1 expression is driven by the transcription factors p53 or ATF4 rather than HIF1 (refs 104-106) . The ATF4-mediated expression of REDD1 seems to be independent of energy stress. Rather, it is stimulated downstream of endoplasmic reticulum (ER) stress, resulting from the deleterious effects of glucose starvation, 2-deoxyglucose or hypoxia on protein maturation in the ER (refs 105,107,108) . In general, the sensitivity of protein glycosylation and disulfide bond formation to the availability of glucose and oxygen, respectively, renders the ER (and the adaptive stress response originating therein, known as the unfolded protein response) a key component of cellular nutrient sensing. It seems likely that the relative contributions of acute activation of AMPK and the transcriptional induction of REDD1 to inhibitory signals affecting mTORC1 in response to hypoxia will depend on many factors, including: the duration of exposure to hypoxia; the dependence of the cell on oxidative metabolism; the secretory properties of the cell; and the tissue microenvironment 94, 109, 110 . Similar principles are likely to apply to glucose deprivation and various other forms of nutrient and energy stress.
In addition to the mechanisms discussed above, pathways by which glucose and energy stress impinge on mTORC1 signalling independently of the TSC complex have also emerged. Depletion of cellular energy levels can activate the stress-responsive mitogen-activated protein kinase p38 and its direct target p38-regulated/activated kinase (PRAK), albeit through an unknown mechanism 111, 112 . In cells deficient for either the β isoform of p38 (p38β) or PRAK, mTORC1 signalling is largely unresponsive to 2-deoxyglucose, which blocks glycolysis and other glucoseutilizing processes, suggesting that the p38β-PRAK pathway is required to suppress mTORC1 signalling under such conditions 112 . It seems that this pathway inhibits mTORC1 signalling through the PRAK-mediated phosphorylation of Ser 130 on Rheb, which is proposed to disrupt its ability to bind GTP. Other studies, however, have found that p38-dependent signalling stimulates, rather than inhibits, mTORC1 (refs 113-115) . Severe conditions of energy stress, such as that caused by combined glucose and glutamine starvation in cell culture, can even impair the assembly of mTORC1, thereby overriding all other upstream regulatory events 116 . This occurs by disrupting the association between mTOR and the Tel2-Tti1-Tti2 (TTT)-RUVBL1/2 complex, which is required for the proper folding and stability of mTOR and related kinases 117, 118 . Within the TTT-RUVBL complex, the ATPase activity of RUVBL is susceptible to cellular ATP depletion, and loss of this activity results in a defect in higher-order assembly of mTORC1 into a homodimer 116 , which is the functional signalling complex 119 . There is genetic evidence that the Rag GTPases are also involved in glucose sensing by mTORC1. It has been found that mouse embryonic fibroblasts that are homozygous for a constitutively GTP-bound mutant of RagA (RagA GTP ) are resistant to the inhibitory effects of either amino acid or glucose withdrawal on mTORC1 signalling 65 . Furthermore, due to an inability to downregulate mTORC1 in response to a natural drop in blood glucose levels immediately after birth, RagA GTP/GTP neonates perish before suckling. An independent study also provided evidence that the Rag GTPases are involved in the sensing of some forms of energy stress by mTORC1 (ref. 120) . It is predicted from these studies that the GTP/GDP-loading state of the RagA/B-RagC/D heterodimer is affected by glucose withdrawal or energy-stress-inducing conditions, but as is the case for amino acids, the sensing mechanism is currently unknown. It is interesting to note that in both yeast and mammalian cells, glucose starvation has been found to induce an acute disassembly of v-ATPase, and this is rapidly reversed by reintroduction of glucose 121, 122 . Such a mechanism could influence the ability of the v-ATPase complex to stimulate Ragulator GEF activity, thereby blocking RagA/B-GTP loading and the recruitment of mTORC1 to the lysosome during glucose starvation.
The myriad of mechanisms (that have been uncovered so far) by which decreases in intracellular glucose, oxygen and/or ATP lead to inhibition of mTORC1, even in the presence of growth factors, underscore the importance of attenuating mTORC1 signalling and its downstream anabolic processes for adapting to nutrient and energy depletion.
Conclusions and outstanding questions
The mTORC1 signalling network integrates information about the complex nutrient environment of individual cells, tissues and organisms to mount an appropriate physiological response. Although impressive progress has been made over the past decade in understanding mTORC1 signalling, critical questions remain. For instance, apart from AMPK and the prolyl hydroxylases upstream of HIF1, direct sensors of nutrients and metabolites within the upstream signalling network have not yet been identified. Importantly, the molecular details by which signals impinge on mTORC1 regulation have been revealed, almost exclusively, through cell culture studies under largely non-physiological conditions. The experimental comparison of two extreme conditions, such as complete removal of a specific nutrient followed by acute re-feeding, has been essential to provide robust biochemical and cell biological readouts to characterize the signalling mechanisms underlying a given response. Although the molecular pathways characterized in such studies are likely to be similar in vivo, we must define the signals that dominantly control mTORC1 in different tissues -where, unlike in cell culture models, mTORC1 is generally in the 'off´ state and only transiently activated in response to specific stimuli. Cell culture experiments suggest that nutrients only basally activate mTORC1, but the relative contribution of nutrient and growth factor signals to mTORC1 activation in vivo is poorly understood. Conditions referred to as 'energy stress' in cell culture models, which are maintained under super-physiological levels of growth factors and nutrients, are likely to be closer to the homeostatic state in vivo. This is illustrated by the fact that loss of the LKB1 tumour suppressor, which is required for AMPK activation by energy stress, results in the formation of gastrointestinal polyps that exhibit high levels of mTORC1 signalling relative to the normal epithelium 92 . Therefore, removal of the inhibitory signal from AMPK in this setting is sufficient to activate mTORC1.
Consistent with cell culture studies, mTORC1 signalling in the liver is inhibited under fasting conditions through a pathway dependent on the TSC complex 123 . However, feeding induces a robust and transient activation of mTORC1 in this tissue through a mechanism that seems to be independent of insulin signalling 124 , suggesting that an unknown nutrient input might be dominating this response. Under conditions of dietary (or calorie) restriction, which has been shown to prolong the lifespan of many organisms through mechanisms believed to involve mTORC1 inhibition, the attenuation of mTORC1 signalling in different tissues is likely to reflect decreases in specific local nutrients, as well as circulating insulin and IGF1 (refs 125,126) . The importance of defining the molecular mechanisms and hierarchy of signals that regulate mTORC1 signalling in vivo is highlighted by the diverse disease settings in which mTORC1 is aberrantly activated, including ageing-related diseases such as cancer and diabetes.
